The shares of the leading healthcare company gained up to 5 percent after the Government of Singapore and ICICI Prudential Mutual Fund snap up 4.3 percent and 0.97 percent equity shares in the company, respectively.
With a market capitalization of Rs 8,001.29 crore, the shares of Medplus Health Services Ltd were trading at Rs 667.20 per share increasing around 4.63 percent as compared to the previous closing price of Rs 637.65 apiece.
Reason for Rise:-
Today the shares of the company have seen positive movement after the Government of Singapore and ICICI Prudential Mutual Fund snapped up 11.54 lakh and 5.09 lakh equity shares respectively, at an average price of Rs 616 apiece, however, Foreign company Lavender Rose Investment exited Medplus by selling its entire shareholding of 1.3 crore equity share, representing 11.35% in the company at an average price of Rs 616.48 per share.
Also read
Financial performance:-
Analyzing a company’s financial performance, revenue zoomed by 16 percent from Rs 1,284 crore in Q1FY24 to Rs 1,489 crore in Q1FY25, during the same time frame, the company’s net profit zoomed significantly by 250 percent from Rs 4 crore to Rs 14 crore.
Manufacturing facilities:-
The company has three manufacturing plants in Telangana (Jeedimetla, Moosapet, and Pashamylaram). At Jeedimetla, it manufactures a range of plastic products, including medicine trays, nebulizers, vaporizers, plastic bottles and caps, and other plastic products.
Ratio analysis:-
The company’s critical ratios show that the return on equity increased from 0.48 percent in FY22-23 to 0.81 percent in FY23-24, while the return on capital employed increased from 1.15 percent to 1.22 percent. The net profit margin (NPM) for fiscal year 23-24 is 2.05 percent.
Company snapshot:-
MedPlus Health Services Limited principally sells pharmaceuticals and other general merchandise, provides wholesale cash and carry and pathological laboratory testing services, and trades and manufactures pharmaceutical products, fast-moving consumer goods, and beauty products.
Written by:- Abhishek Singh
Also read
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
